IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.

Similar documents
á467ñ RESIDUAL SOLVENTS

E17 ETHYLCELLULOSE. Revision 3 Stage 4

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

VOLUNTARY MONOGRAPH. Council for Responsible Nutrition March 2006

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

ISO INTERNATIONAL STANDARD. Animal and vegetable fats and oils Determination of individual and total sterols contents Gas chromatographic method

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

Q3C Tables and List Guidance for Industry

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

DEVELOPMENT AND VALIDATION OF GAS CHROMATOGRAPHY METHODS FOR THE CONTROL OF VOLATILE IMPURITIES IN THE PHARMACEUTICAL SUBSTANCE DUTASTERIDE

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

METHOD OF ANALYSIS DETERMINATION OF THE COMPOSITION AND CONTENT OF STEROLS BY CAPILLARY-COLUMN GAS CHROMATOGRAPHY

DETERMINATION OF COMPOSITION OF TRIACYLGLYCEROLS AND COMPOSITION AND CONTENT OF DI-ACYLGLYCEROLS BY CAPILLARY GAS CHROMATOGRAPHY, IN VEGETABLE OILS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Evaluating the Isolation and Quantification of Sterols in Seed Oils by Solid-Phase Extraction and Capillary Gas Liquid Chromatography

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Draft proposal for The International Pharmacopoeia

METHOD OF ANALYSIS DETERMINATION OF THE COMPOSITION AND CONTENT OF STEROLS AND TRITERPENE DIALCOHOLS BY CAPILLARY COLUMN GAS CHROMATOGRAPHY

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

CORESTA RECOMMENDED METHOD NÄ 9

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

β-carotene-rich Extract From Dunaliella Salina

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

MONOGRAPHS (USP) Saccharin Sodium

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

Column Chromatographic Isolation of Docosahexaenoic Acid from Fish Oil and its Assessment by Analytical Techniques

DEVELOPMENT AND VALIDATION OF THE GC METHOD FOR THE QUANTITATIVE DETERMINATION OF SEMI-VOLATILE SOLVENTS IN THE PHARMACEUTICAL SUBSTANCE BOSENTAN

Lutein Esters from Tagetes Erecta

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Sucrose Esters of Fatty Acids

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Heparin Sodium ヘパリンナトリウム

Title Revision n date

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

CORESTA RECOMMENDED METHOD N 8

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

EMTRICITABINE AND TENOFOVIR TABLETS

CORESTA Recommended Method No. 84

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

CLINDAMYCIN PALMITATE

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

SUCROSE OLIGOESTERS TYPE I

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

TWA [2] (mg/m3) [5] (ppm) [6]

Measuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

Rapid Separation of Fatty Acid Methyl Esters

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

METHOD 8316 ACRYLAMIDE, ACRYLONITRILE AND ACROLEIN BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)

Ergovaline. [Methods listed in the Feed Analysis Standards] 1 Liquid chromatography Note 1, 2 [Feed Analysis Standards, Chapter 5, Section 2

DETERMINATION OF ALIPHATIC AND TRITERPENIC ALCOHOLS CONTENT BY CAPILLARY GAS CHROMATOGRAPHY

PHARMA SCIENCE MONITOR

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

HEPARIN SODIUM. Heparinum natricum

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

Antioxidant. [Summary of antioxidant]

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Forensic Analysis of Blood Alcohol Concentration

Conversion of Biomass-derived Fatty Acids and Derivatives. into Hydrocarbons Using a Meta-Free Hydrodeoxygenation. Process

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

DRAFT TANZANIA STANDARD

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

VICH GL18(R): Impurities: Residual solvents in new veterinary medicinal products, active substances and excipients (Revision)

DriSolv. Anhydrous solvents for organic synthesis. EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

VICH GL 18 residual solvents in new veterinary medicinal products, active substances and excipients (Revision)

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

INTERNATIONAL OLIVE COUNCIL

Pelagia Research Library

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Journal of Chemical and Pharmaceutical Research

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Supported Liquid Extraction (SLE) For Food Applications

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Transcription:

EUROPEAN PHARMACOPOEIA 6.0 2.4.24. Identification and control of residual solvents paper and wash each filter with 3 quantities, each of 15 ml, of methylenechlorider.placethecombinedfiltrateand washings from each filter separately in 3 flasks, evaporate under a stream of nitrogen R to 5-10 ml. Transfer to a small test tube and evaporate to dryness under a stream of nitrogen R. DETERMINATION OF THE STEROLS Gas chromatography (2.2.28). Carry out the operations protected from humidity and prepare the solutions immediately before use. Test solution. To the sterols separated from the substance to be examined by thin-layer chromatography add a freshly prepared mixture of 0.04 ml of chlorotrimethylsilane R, 0.1 ml of hexamethyldisilazane R and 0.5 ml of anhydrous pyridine R. Allow to stand for at least 5 min and use the liquid phase. Reference solution (a). To9partsofthesterolsseparated from rapeseed oil R by thin-layer chromatography add 1partofcholesterol R. Tothemixtureaddafreshly prepared mixture of 0.04 ml of chlorotrimethylsilane R, 0.1 ml of hexamethyldisilazane R and 0.5 ml of anhydrous pyridine R. Allow to stand for at least 5 min and use the liquid phase. Reference solution (b). To the sterols separated from sunflower oil R by thin-layer chromatography add a freshly prepared mixture of 0.04 ml of chlorotrimethylsilane R, 0.1 ml of hexamethyldisilazane R and 0.5 ml of anhydrous pyridine R. Allow to stand for at least 5 min and use the liquid phase. Column: material: fusedsilica, size: l = 20-30 m, Ø = 0.25-0.32 mm, stationary phase: poly[methyl(95)phenyl(5)]siloxane R or poly(cyanopropyl)(7)(phenyl)(7)(methyl)(86)siloxane R (film thickness 0.25 µm). Carrier gas: hydrogen for chromatography R or helium for chromatography R. Linear velocity: 30-50 cm/s (hydrogen) or 20-35 cm/s (helium). Split ratio: 1:50or1:100. Temperature: column: 260 C, injection port: 280 C, detector: 290 C. Detection: flameionisation. Injection: 1µl. Results: the chromatogram obtained with reference solution (a) shows 4 principal peaks corresponding to cholesterol, brassicasterol, campesterol and β-sitosterol and the chromatogram obtained with reference solution (b) shows 4 principal peaks corresponding to campesterol, stigmasterol, β-sitosterol and 7-stigmastenol. The retention timesofthesterolswithreferencetoβ-sitosterol are given in Table 2.4.23.-1. Table 2.4.23.-1. Retention times of sterols with reference to β-sitosterol for two different columns Poly(cyanopropyl)(7)- (phenyl)(7)- Poly[methyl(95)- phenyl(5)]siloxane (methyl)(86)siloxane Cholesterol 0.64 0.63 Brassicasterol 0.70 0.71 24-Methylenecholesterol 0.79 0.80 Campesterol 0.82 0.81 Campestanol 0.83 0.82 Stigmasterol 0.87 0.87 7-Campesterol 0.93 0.92 5,23-Stigmastadienol 0.95 0.95 Clerosterol 0.96 0.96 β-sitosterol 1 1 Sitostanol 1.01 1.02 5-Avenasterol 1.03 1.03 5,24-Stigmastadienol 1.09 1.08 7-Stigmastenol (1) 1.13 1.12 7-Avenasterol 1.18 1.16 Betulin 1.4 1.4 (1) This sterol may also be referred to as 7-stigmasterol in literature. The peak of the internal standard (betulin) must be clearly separated from the peaks of the sterols to be determined. For the chromatogram obtained with the test solution, identify the peaks and calculate the percentage content of each sterol in the sterol fraction of the substance to be examined using the following expression: A = area of the peak due to the component to be determined, S = sumoftheareasofthepeaksduetothe components indicated in Table 2.4.23.-1. If required in the monograph, calculate the content of each sterol in milligrams per 100 grams of the substance to be examined using the following expression: A = area of the peak due to the component to be determined, A = area of the peak due to betulin, m = massofthesampleofthesubstancetobe examined in grams, m = mass of betulin R added in milligrams. 01/2008:20424 2.4.24. IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS The test procedures described in this general method may be used: i. for the identification of the majority of Class 1 and Class 2 residual solvents in an active substance, excipient or medicinal product when the residual solvents are unknown; GeneralNotices(1)applytoallmonographsandothertexts 121

2.4.24. Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.0 ii. as a limit test for Class 1 and Class 2 solvents when present in an active substance, excipient or medicinal product; iii. for the quantification of Class 2 solvents when the limits are greater than 1000 ppm (0.1 per cent) or for the quantification of Class 3 solvents when required. Class 1, Class 2 and Class 3 residual solvents are listed in general chapter 5.4. Residual solvents. Three diluents are described for sample preparation and theconditionstobeappliedforhead-spaceinjectionof the gaseous sample onto the chromatographic system. Two chromatographic systems are prescribed but System A is preferred whilst System B is employed normally for confirmation of identity. The choice of sample preparation proceduredependsonthesolubilityofthesubstancetobe examined and in certain cases the residual solvents to be controlled. The following residual solvents are not readily detected by the head-space injection conditions described: formamide, 2-ethoxyethanol, 2-methoxyethanol, ethylene glycol, N-methylpyrrolidone and sulfolane. Other appropriate procedures should be employed for the control of these residual solvents. When the test procedure is applied quantitatively to control residual solvents in a substance, then it must be validated. PROCEDURE Examine by gas chromatography with static head-space injection (2.2.28). Sample preparation 1. This is intended for the control of residual solvents in water-soluble substances. Sample solution (1). Dissolve 0.200 g of the substance to be examined in water R and dilute to 20.0 ml with the same solvent. Sample preparation 2. This is intended for the control of residual solvents in water-insoluble substances. Sample solution (2). Dissolve 0.200 g of the substance to be examined in N,N-dimethylformamide R (DMF) and dilute to 20.0 ml with the same solvent. Sample preparation 3. This is intended for the control of N,N-dimethylacetamide and/or N,N-dimethylformamide, when it is known or suspected that one or both of these substances are present in the substance to be examined. Sample solution (3). Dissolve 0.200 g of the substance to be examined in 1,3-dimethyl-2-imidazolidinone R (DMI) and dilute to 20.0 ml with the same solvent. Insomecasesnoneoftheabovesamplepreparation procedures are appropriate, in which case the diluent to be used for the preparation of the sample solution and the static head-spaceconditionstobeemployedmustbedemonstrated to be suitable. Solvent solution (a). To1.0mlofClass 1 residual solvent solution CRS, add9mlofdimethyl sulphoxide R and dilute to 100.0 ml with water R. Dilute 1.0 ml of this solution to 100 ml with water R. Dilute 1.0 ml of this solution to 10.0 ml with water R. The reference solutions correspond to the following limits: benzene: 2 ppm, carbon tetrachloride: 4 ppm, 1,2-dichloroethane: 5 ppm, 1,1-dichloroethene: 8 ppm, 1,1,1-trichloroethane: 10 ppm. Solvent solution (b). Dissolve appropriate quantities of the Class 2 residual solvents in dimethyl sulphoxide R and dilute to 100.0 ml with water R. Dilute to give a concentration of 1/20 of the limits stated in Table 2 (see 5.4. Residual solvents). Solvent solution (c). Dissolve 1.00 g of the solvent or solvents present in the substance to be examined in dimethyl sulphoxide R or water R, if appropriate, and dilute to 100.0 ml with water R. Dilute to give a concentration of 1/20 of the limit(s) stated in Table 1 or 2 (see 5.4. Residual solvents). Blank solution. Prepare as described for solvent solution (c) but without the addition of solvent(s) (used to verify the absence of interfering peaks). Test solution. Introduce 5.0 ml of the sample solution and 1.0 ml of the blank solution into an Reference solution (a) (Class 1). Introduce 1.0 ml of solvent solution (a) and 5.0 ml of the appropriate diluent into an Reference solution (a 1 )(Class1).Introduce5.0mlofthe sample solution and 1.0 ml of solvent solution (a) into an Reference solution (b) (Class 2). Introduce 1.0 ml of solvent solution (b) and 5.0 ml of the appropriate diluent into an Reference solution (c). Introduce5.0mlofthesample solution and 1.0 ml of solvent solution (c) into an injection vial. Reference solution (d). Introduce 1.0 ml of the blank solution and 5.0 ml of the appropriate diluent into an Close the vials with a tight rubber membrane stopper coated with polytetrafluoroethylene and secure with an aluminium crimped cap. Shake to obtain a homogeneous solution. The following static head-space injection conditions may be used: Sample preparation procedure Operating parameters 1 2 3 Equilibration temperature ( C) 80 105 80 Equilibration time (min) 60 45 45 Transfer-line temperature ( C) 85 110 105 Carrier gas: Nitrogen for chromatography R or Helium for chromatography R at an appropriate pressure Pressurisation time (s) 30 30 30 Injection volume (ml) 1 1 1 The chromatographic procedure may be carried out using: SYSTEM A a fused-silica capillary or wide-bore column 30 m long and 0.32 mm or 0.53 mm in internal diameter coated with cross-linked 6 per cent polycyanopropylphenylsiloxane and 94 per cent polydimethylsiloxane (film thickness: 1.8 µm or 3 µm), nitrogen for chromatography R or helium for chromatography R as the carrier gas, split ratio 1:5 with a linear velocity of about 35 cm/s, a flame-ionisation detector (a mass spectrometer may also be used or an electron-capture detector for the chlorinated residual solvents of Class 1), 122 See the information section on general monographs (cover pages)

EUROPEAN PHARMACOPOEIA 6.0 2.4.24. Identification and control of residual solvents maintaining the temperature of the column at 40 C for 20 min, then raising the temperature at a rate of 10 C per min to 240 C and maintaining it at 240 C for 20 min and maintaining the temperature of the injection port at 140 C and that of the detector at 250 C, or, where there is interference from the matrix, use: SYSTEM B a fused-silica capillary or wide-bore column 30 m long and 0.32 mm or 0.53 mm in internal diameter coated with macrogol 20 000 R (film thickness: 0.25 µm), nitrogen for chromatography R or helium for chromatography R as the carrier gas, split ratio 1:5 with a linear velocity of about 35 cm/s. a flame-ionisation detector (a mass spectrophotometer may also be used or an electron-capture detector for the chlorinated residual solvents of Class 1), maintaining the temperature of the column at 50 C for 20 min, then raising the temperature at a rate of 6 C per min to 165 C and maintaining it at 165 C for 20 min and maintaining the temperature of the injection port at 140 C and that of the detector at 250 C. Inject 1 ml of the gaseous phase of reference solution (a) onto the column described in System A and record the chromatogram under such conditions that the signal-to-noise ratio for 1,1,1-trichloroethane can be measured. The signal-to-noise ratio must be at least five. A typical chromatogramisshowninfigure2.4.24.-1. Inject 1 ml of the gaseous phase of reference solution (a 1 ) onto the column described in System A. The peaks due to the Class 1 residual solvents are still detectable. Inject 1 ml of the gaseous phase of reference solution (b) onto the column described in System A and record the chromatogram under such conditions that the resolution betweenacetonitrileandmethylenechloridecanbe determined. The system is suitable if the chromatogram obtained resembles the chromatogram shown in Figure 2.4.24.-2 and the resolution between acetonitrile and methylenechlorideisatleast1.0. Inject 1 ml of the gaseous phase of the test solution onto the column described in System A. If in the chromatogram obtained, there is no peak which corresponds to one of the residual solvent peaks in the chromatograms obtained with reference solution (a) or (b), then the substance to be examined meets the requirements of the test. If any peak in the chromatogram obtained with the test solution corresponds to any of the residual solvent peaks obtained with reference solution (a) or (b) then System B is to be employed. Inject 1 ml of the gaseous phase of reference solution (a) onto the column described in System B and record the chromatogram under such conditions that the signal-to-noise ratio for benzene can be measured. The signal-to-noise ratio must be at least five. A typical chromatogram is shown in Figure 2.4.24.-3. Inject 1 ml of the gaseous phase of reference solution (a 1 ) onto the column described in System B. The peaks due to the Class I residual solvents are still detectable. Inject 1 ml of the gaseous phase of reference solution (b) onto the column described in System B and record the chromatogram under such conditions that the resolution between acetonitrile and trichloroethene can be determined. The system is suitable if the chromatogram obtained resembles the chromatogram shown in Figure 2.4.24.-4 and the resolution between acetonitrile and trichloroethene is at least 1.0. Inject 1 ml of the gaseous phase of the test solution onto the column described in System B. If in the chromatogram obtained, there is no peak which corresponds to any of the residual solvent peaks in the chromatogram obtained with the reference solution (a) or (b), then the substance to be examined meets the requirements of the test. If any peak in the chromatogram obtained with the test solution corresponds to any of the residual solvent peaks obtained with reference solution (a) or (b) and confirms the correspondence obtained when using System A, then proceed as follows. Inject 1 ml of the gaseous phase of reference solution (c) onto the column described for System A or System B. If necessary, adjust the sensitivity of the system so that the height of the peak corresponding to the identified residual solvent(s) is at least 50 per cent of the full scale of the recorder. Inject 1 ml of the gaseous phase of reference solution (d) onto the column. No interfering peaks should be observed. Inject 1 ml of the gaseous phase of the test solution and 1 ml of the gaseous phase of reference solution (c) on to the column. Repeat these injections twice more. The mean area of the peak of the residual solvent(s) in the chromatograms obtained with the test solution is not greater than half the mean area of the peak of the corresponding residual solvent(s) in the chromatograms obtained with reference solution (c). The test is not valid unless the relative standard deviation of the differences in areas between the analyte peaks obtained from three replicate paired injections of reference solution (c) and the test solution, is at most 15 per cent. A flow diagram of the procedure is shown in Figure 2.4.24.-5. When a residual solvent (Class 2 or Class 3) is present at a level of 0.1 per cent or greater then the content may be quantitatively determined by the method of standard additions. GeneralNotices(1)applytoallmonographsandothertexts 123

2.4.24. Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.0 1. 1,1-dichloroethene 2. 1,1,1-trichloroethane 3. carbon tetrachloride 4. benzene 5. 1,2-dichloroethane Figure 2.4.24.-1. Typical chromatogram of class 1 solvents using the conditions described for System A and Procedure 1. Flame-ionisation detector. 1. methanol 5. cis-1,2-dichloroethene 9. 1,2-dimethoxymethane 13. pyridine 16. chlorobenzene 2. acetonitrile 6. nitromethane 10. 1,1,2-trichloroethene 14. toluene 17. xylene ortho, meta, para 3. dichloromethane 7. chloroform 11. methylcyclohexane 15. 2-hexanone 18. tetralin 4. hexane 8. cyclohexane 12. 1,4-dioxan Figure 2.4.24.-2. Chromatogram of Class 2 solvents using the conditions described for System A and Procedure 1. Flame-ionisation detector. 124 See the information section on general monographs (cover pages)

EUROPEAN PHARMACOPOEIA 6.0 2.4.24. Identification and control of residual solvents 1. 1,1-dichloroethene 2. 1,1,1-trichloroethane 3. carbon tetrachloride 4. benzene 5. 1,2-dichloroethane Figure 2.4.24.-3. Chromatogram of Class 1 residual solvents using the conditions described for System B and Procedure 1. Flame-ionisation detector. 1. methanol 5. cis-1,2-dichloroethene 9. 1,2-dimethoxyethane 13. pyridine 16. chlorobenzene 2. acetonitrile 6. nitromethane 10. 1,1,2-trichloroethene 14. toluene 17. xylene ortho, meta, para 3. dichloromethane 7. chloroform 11. methylcyclohexane 15. 2-hexanone 18. tetralin (t R =28min) 4. hexane 8. cyclohexane 12. 1,4-dioxan Figure 2.4.24.-4. Typical chromatogram of class 2 residual solvents using the conditions described for System B and Procedure 1. Flame-ionisation detector. GeneralNotices(1)applytoallmonographsandothertexts 125

2.4.25. Ethylene oxide and dioxan EUROPEAN PHARMACOPOEIA 6.0 Figure 2.4.24.-5. Diagram relating to the identification of residual solvents and the application of limit tests 2.4.25. ETHYLENE OXIDE AND DIOXAN 01/2008:20425 The test is intended for the determination of residual ethylene oxide and dioxan in samples soluble in water or dimethylacetamide. For substances that are insoluble or insufficiently soluble in these solvents, the preparation of the sample solution and the head-space conditions to be employed are given in the individual monograph. Examine by head-space gas chromatography (2.2.28). A. For samples soluble in or miscible with water, the following procedure may be used. 126 See the information section on general monographs (cover pages)